title: δ-opioid receptor activation and microRNA expression of the rat cortex in hypoxia.
abstract: Prolonged hypoxic/ischemic stress may cause cortical injury and clinically manifest as a neurological disability. Activation of the δ-opioid receptor (DOR) may induce cortical protection against hypoxic/ischemic insults. However, the mechanisms underlying DOR protection are not clearly understood. We have recently found that DOR activation modulates the expression of microRNAs (miRNAs) in the kidney exposed to hypoxia, suggesting that DOR protection may involve a miRNA mechanism. To determine if the miRNAs expressed in the cortex mediated DOR neuroprotection, we examined 19 miRNAs that were previously identified as hypoxia- and DOR-regulated miRNAs in the kidney, in the rat cortex treated with UFP-512, a potent and specific DOR agonist under hypoxic condition. Of the 19 miRNAs tested, 17 were significantly altered by hypoxia and/or DOR activation with the direction and amplitude varying depending on hypoxic duration and times of DOR treatment. Expression of several miRNAs such as miR-29b, -101b, -298, 324-3p, -347 and 466b was significantly depressed after 24 hours of hypoxia. Similar changes were seen in normoxic condition 24 hours after DOR activation with one-time treatment of UFP-512. In contrast, some miRNAs were more tolerant to hypoxic stress and showed significant reduction only with 5-day (e.g., miR-31 and -186) or 10-day (e.g., miR-29a, let-7f and -511) exposures. In addition, these miRNAs had differential responses to DOR activation. Other miRNAs like miRs-363* and -370 responded only to the combined exposure to hypoxia and DOR treatment, with a notable reduction of >70% in the 5-day group. These data suggest that cortical miRNAs are highly yet differentially sensitive to hypoxia. DOR activation can modify, enhance or resolve the changes in miRNAs that target HIF, ion transport, axonal guidance, free radical signaling, apoptosis and many other functions.
authors.affiliation: The Third Clinical College of Soochow University, Changzhou, Jiangsu, People's Republic of China.
authors.forename: Yilin
authors.initials: Y
authors.lastname: Yang
authors.forename: Feng
authors.initials: F
authors.lastname: Zhi
authors.forename: Xiaozhou
authors.initials: X
authors.lastname: He
authors.forename: Meredith L
authors.initials: ML
authors.lastname: Moore
authors.forename: Xuezhi
authors.initials: X
authors.lastname: Kang
authors.forename: Dongman
authors.initials: D
authors.lastname: Chao
authors.forename: Rong
authors.initials: R
authors.lastname: Wang
authors.forename: Dong H
authors.initials: DH
authors.lastname: Kim
authors.forename: Ying
authors.initials: Y
authors.lastname: Xia
mesh_terms: D000818:Animals; D017209:Apoptosis; D001562:Benzimidazoles / Q000494:pharmacology; D002540:Cerebral Cortex / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism*; D007511:Ischemia / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008297:Male; D035683:MicroRNAs / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D009842:Oligopeptides / Q000494:pharmacology; D016133:Polymerase Chain Reaction / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000378:metabolism*; D013997:Time Factors
chemical_list: C526539:2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide; D001562:Benzimidazoles; D035683:MicroRNAs; D018696:Neuroprotective Agents; D009842:Oligopeptides; D017465:Receptors, Opioid, delta